Answers are grounded in this paper and cite their sources.
Myocardial ECV (bolus or infusion technique) and pre-contrast T1 are biomarkers for cardiac AL amyloid and they predict mortality in systemic amyloidosis.
No takes yet. Share an insight, caveat, or question.
Banypersad et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: